This country profile provides an overview of the Kingdom of Eswatini’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
84%
Bilharzia
100%
River blindness
N/A
0.16 million people received treatment in Eswatini in 2017 0.10 million people did not receive treatment in Eswatini in 2017

Priorities for progress in Eswatini

  • Eswatini is congratulated for consistently high coverage treatments and for setting a pattern for others to follow.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Eswatini does not require mass treatment for elephantiasis.

Blinding trachoma

Eswatini does not require mass treatment for blinding trachoma.

Intestinal worms

Treatment coverage decreased from 86% in 2016 to 84% in 2017.

Pre-sch and school-aged children needing treatment
0.18m
Pre-school and school-aged children receiving treatment
0.15m

Bilharzia

Treatment coverage increased from 94% in 2016 to 100% in 2017.

School-aged children needing treatment
0.11m
School-aged children receiving treatment
0.11m

River blindness

Eswatini does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in eSwatini.